Published
October 1, 2026
Updated
October 3, 2026
Consumers who bought covered generic prescription drugs between May 2009 and December 2019 may qualify to claim a share of about $96.5 million from the state attorneys general generic drug consumer settlement, funded by Apotex, Heritage, Lannett, Bausch and Glenmark. Claims are open through March 8, 2027, and this is a separate claim from the end-payer class action that closes November 9, 2026.
Current Status
Claims are open. Consumers can file at AG Generic Drugs through March 8, 2027. In September 2026 the U.S. District Court for the District of Connecticut preliminarily approved the attorneys general's plan to distribute the money, and the coalition announced the claim period. A final approval date for the distribution plan and a payment date had not been announced as of October 1, 2026.New: Sandoz $400 million. On October 1–2, 2026, the 48-attorney-general coalition announced a final $400 million settlement with Sandoz, which had been announced in principle in August, and filed a motion for preliminary approval in the U.S. District Court for the District of Connecticut. The New York Attorney General says New Yorkers who bought listed generic drugs from May 2009 to December 2019 can claim at AGGenericDrugs.com by March 8, 2027. The court has not yet approved the Sandoz settlement.
This page covers the state attorneys general program only. The generic drug end-payer class action, which includes the Sandoz/Fougera, Sun/Taro and Apotex/Heritage settlements, is a separate claim with an earlier deadline of November 9, 2026; it is explained on its own page, the generic drug end-payer settlements.
Free settlement alerts
Get notified when new class actions open to claims
Join thousands of readers who get the latest class action settlements you may qualify for — delivered straight to your inbox.
Status
Claims Open
state attorneys general consumer program · distribution plan preliminarily approved September 2026
Claim Deadline
March 8, 2027
the separate end-payer class action closes earlier, on November 9, 2026
Settlement Fund
About $96.5 Million
Apotex · Heritage/Emcure · Lannett · Bausch · Glenmark · plus a $400M Sandoz settlement awaiting court approval · consumer share paid pro rata
Proof Required
Yes — Check the Claim Form
the claim asks about covered drugs you bought · keep pharmacy records or receipts ready
What Changed Recently?
In September 2026 a bipartisan coalition of 48 attorneys general, led by Connecticut, announced that the federal court in Connecticut had preliminarily approved their plan to distribute settlement money to consumers, and opened the claim period. Attorneys general in New York, California, Washington, New Jersey and other states issued notices urging residents to file.The money comes from settlements the states reached with five manufacturers accused of conspiring to raise generic drug prices. The companies did not admit liability.
Sandoz settlement, October 2026. On October 1–2, 2026, the coalition announced a final $400 million settlement with Sandoz Inc. and Fougera Pharmaceuticals Inc. over more than 100 generic drugs, including antibiotics, antidepressants, contraceptives and anti-inflammatory drugs. According to the New York Attorney General, Sandoz will pay $320,560,180 with interest over seven years, for a total of $400 million, and the Iowa Attorney General says Sandoz will pay about $469 million in all once earlier settlements with individual states are counted. Sandoz also agreed to internal compliance reforms. Attorneys general in Iowa and Pennsylvania say a motion for preliminary approval was filed in the U.S. District Court for the District of Connecticut that week. The settlement resolves allegations, and Sandoz has not been found liable.
The attorneys general are sending consumers to the same place for the Sandoz money: their announcements direct people to AGGenericDrugs.com, and the New York Attorney General gives the same March 8, 2027 deadline. They do not say whether a claim already filed in the current program will also count for the Sandoz money, or whether the Sandoz share will be added to the current distribution or paid in a later round. OCA will update this page when the program website or the court spells that out.
| Company | Amount |
|---|---|
| Apotex | $39,100,000 |
| Glenmark | $29,600,000 |
| Lannett | $13,770,000 |
| Heritage and its parent Emcure | $10,000,000 |
| Bausch | $4,080,000 |
Is This the Same as the End-Payer Settlement?
No. There are two consumer programs, and they are easy to confuse:| State AG program (this page) | End-payer class action | |
|---|---|---|
| Deadline | March 8, 2027 | November 9, 2026 |
| Money | About $96.5M from Apotex, Heritage, Lannett, Bausch, Glenmark, plus $400M from Sandoz pending court approval | $533M from Sandoz/Fougera, Sun/Taro, Apotex/Heritage |
| Who brings it | 48 state attorneys general (D. Conn.) | Class counsel in a federal MDL (E.D. Pa.) |
| Where to file | AG Generic Drugs | End-payer settlement page |
A consumer who qualifies for both can file in both, but each needs its own claim. Because the end-payer deadline comes first, file that one first.
There are two different Sandoz settlements for consumers. The $275 million Sandoz/Fougera class settlement is claimed through the end-payer program by November 9, 2026. The $400 million Sandoz settlement with the states, finalized in October 2026 and awaiting court approval, is the one the attorneys general are directing consumers to claim through AGGenericDrugs.com.
Who Qualifies?
Consumers who purchased one or more of the covered generic drugs in the United States between May 2009 and December 2019 may be eligible. The program's website lists the covered drugs and the eligibility rules; OCA also keeps a covered generic drugs list. This program is for individual consumers. Health insurers and employer plans that reimbursed drug costs are covered by the end-payer class action instead.How Much Can You Get?
No per-person amount has been announced. Consumer payments come from a fixed pool and are divided pro rata among valid claims, and the attorneys general have said each person's share depends on factors including how much they spent on the covered drugs. The final amount depends on how many valid claims are filed.What Proof Is Required?
The claim asks which covered drugs you bought and about your purchases during May 2009 through December 2019. Check the claim form on the program's website for exactly which records it accepts, and gather pharmacy records, prescription receipts or account statements before you start; most pharmacies can print a prescription history covering past years. Claims can be reviewed and rejected for inadequate support.What Is the Deadline?
Submit your claim by March 8, 2027. If you also qualify for the end-payer class action, its deadline is November 9, 2026.How Do You File?
File at AGGenericDrugs.com, where the claim form, drug list and instructions are posted. You do not need to pay anyone to file.What Happens Next?
Claims stay open until March 8, 2027. The court preliminarily approved the distribution plan in September 2026; payments follow the court's final approval of the plan and the review of claims, and no date for either had been announced as of October 1, 2026. The court must also decide whether to preliminarily approve the $400 million Sandoz settlement, which the states filed in early October 2026; Sandoz pays over seven years. The states' litigation against other generic drug makers continues.Sources and Verification
- Official program website — AG Generic Drugs
- Connecticut Attorney General announcement of the consumer claim process (September 2026)
- New York Attorney General announcement (September 2026)
- California Attorney General announcement (September 2026)
- Washington Attorney General announcement (September 2026)
- New York Attorney General — $400 million Sandoz settlement (October 1, 2026)
- Iowa Attorney General — court approval sought for the Sandoz settlement (October 2, 2026)
- Pennsylvania Attorney General — Sandoz settlement filed for approval (October 2, 2026)
Questions
Is the AG generic drug settlement the same as the end-payer settlement?
No. The state attorneys general program at AGGenericDrugs.com is a government enforcement action with its own money, website, claim form and March 8, 2027 deadline. The end-payer class action, funded by Sandoz/Fougera, Sun/Taro and Apotex/Heritage, is a separate claim with a November 9, 2026 deadline. Filing in one does not file you in the other.
Does the AG generic drug program include the Sandoz settlement?
The states are pointing consumers to it. On October 1–2, 2026, the attorneys general finalized a $400 million settlement with Sandoz and asked the federal court in Connecticut for preliminary approval, and their announcements direct consumers to AGGenericDrugs.com, with New York giving the same March 8, 2027 claim deadline. The court has not yet approved the Sandoz settlement, and the announcements do not say whether people who already filed must file again. The separate $275 million Sandoz/Fougera class settlement is claimed through the end-payer program, due November 9, 2026.
How much will I get from the AG generic drug program?
No per-person amount has been announced. Consumer payments come from a fixed pool and are shared pro rata among valid claims, and the attorneys general have said the amount depends on how much a consumer spent on the covered drugs.
Can I file in both generic drug programs?
Yes, if you qualify for both. A consumer who paid for covered generic drugs between May 2009 and December 2019 can file an end-payer claim by November 9, 2026 and a separate state attorneys general claim by March 8, 2027. Each needs its own claim on its own website.
For more class actions keep scrolling below.
Settlement Amount
About $96,500,000
Apotex $39.1M · Glenmark $29.6M · Lannett $13.77M · Heritage/Emcure $10M · Bausch $4.08M
Case Title
State attorneys general generic drug price-fixing actions
Court
U.S. District Court, District of Connecticut
Claim Deadline
March 8, 2027
Brought By
48 state and territorial attorneys general, led by Connecticut
Official Website
AG Generic Drugs.com
